SCHEMBL8772367

SCHEMBL8772367

CC(C(=O)CN1CCC1=O)C(SCc1ccccc1)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.43
ALDH1A1 P00352 3/20 0.39
KDM4E B2RXH2 1/20 0.39
POLB P06746 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
SLC1A2 P43004 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
GAA P10253 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
PPARG P37231 1/20 0.34
PPARA Q07869 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8772451 0.76 LMNA (0.40) LMNAALDH1A1KDM4EPOLBCYP1A2
SCHEMBL8772464 0.72 KMT2A (0.45) L3MBTL1MEN1KMT2A
SCHEMBL8766432 0.67 HTT (0.40) LMNAALDH1A1HTTL3MBTL1MEN1
SCHEMBL8772426 0.67 TRPA1 (0.41) LMNA
SCHEMBL18165400 0.65 EPHX1 (0.62) ALDH1A1KDM4ESMN1; SMN2L3MBTL1GAA
SCHEMBL18165401 0.65 EPHX1 (0.62) ALDH1A1KDM4ESMN1; SMN2L3MBTL1GAA
SCHEMBL8552278 0.65 HMOX1 (0.48) LMNAALDH1A1HTTSMN1; SMN2L3MBTL1
SCHEMBL8767339 0.64 HTT (0.38) LMNAALDH1A1HTTMEN1KMT2A
SCHEMBL8553752 0.64 CACNA2D1 (0.40) LMNAPOLBCYP2C9HTTL3MBTL1
SCHEMBL9708647 0.64 ALDH1A1 (0.51) LMNAALDH1A1CYP1A2CYP2C9HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0799200-A1 SUBSTITUTED AZETIDIN-2-ONES FOR TREATMENT OF ATHEROSCLEROSIS SMITHKLINE BEECHAM PLC (GB) 1997-10-08 EP disclosed